NPI: 1851467666 · MIAMI, FL 33136 · Multi-Specialty Clinic/Center · NPI assigned 11/27/2006
Authorized official KNIGHT, MARK controls 20+ related entities in our dataset. Read more
| Authorized Official | KNIGHT, MARK (CHIEF FINANCIAL OFFICER) |
| Parent Organization | PUBLIC HEALTH TRUST OF MIAMI DADE COUNTY |
| NPI Enumeration Date | 11/27/2006 |
Other providers sharing the same authorized official: KNIGHT, MARK
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,786 | $65K |
| 2019 | 6,835 | $180K |
| 2020 | 4,933 | $134K |
| 2021 | 7,725 | $208K |
| 2022 | 6,355 | $206K |
| 2023 | 1,789 | $78K |
| 2024 | 944 | $40K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 5,538 | 4,937 | $378K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2,525 | 1,958 | $232K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3,169 | 2,710 | $160K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 941 | 889 | $43K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3,782 | 2,583 | $34K |
| 81003 | 2,577 | 1,689 | $19K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 159 | 144 | $14K |
| 80053 | Comprehensive metabolic panel | 1,060 | 906 | $9K |
| 86803 | 730 | 663 | $6K | |
| 84443 | Thyroid stimulating hormone (TSH) | 424 | 383 | $4K |
| 99381 | 29 | 28 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 360 | 328 | $2K |
| 80061 | Lipid panel | 435 | 362 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1,649 | 1,438 | $1K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 14 | 12 | $1K |
| 86850 | 347 | 303 | $855.99 | |
| 0064U | 461 | 410 | $728.68 | |
| 81001 | 226 | 208 | $299.02 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 538 | 467 | $283.71 |
| 82677 | 45 | 44 | $183.45 | |
| G0008 | Administration of influenza virus vaccine | 103 | 80 | $160.11 |
| 90654 | 67 | 52 | $146.05 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 821 | 705 | $97.70 |
| 82950 | 38 | 36 | $91.35 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 162 | 147 | $85.55 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 734 | 662 | $76.42 |
| 88142 | 14 | 13 | $62.71 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 793 | 702 | $46.11 |
| 87340 | 717 | 652 | $9.22 | |
| 86900 | 319 | 290 | $0.00 | |
| 90670 | 522 | 502 | $0.00 | |
| 81243 | 76 | 63 | $0.00 | |
| 86787 | 238 | 208 | $0.00 | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 104 | 92 | $0.00 |
| 84702 | 77 | 72 | $0.00 | |
| 86336 | 45 | 44 | $0.00 | |
| 81401 | 14 | 12 | $0.00 | |
| 81329 | 45 | 39 | $0.00 | |
| 86762 | 365 | 322 | $0.00 | |
| 85660 | 248 | 224 | $0.00 | |
| 86780 | 305 | 262 | $0.00 | |
| 86901 | 339 | 305 | $0.00 | |
| 90677 | 33 | 31 | $0.00 | |
| 90697 | 27 | 26 | $0.00 | |
| 87070 | 46 | 44 | $0.00 | |
| 90686 | 58 | 56 | $0.00 | |
| 82105 | 48 | 46 | $0.00 |